Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy
Crohn’s disease (CD) and ulcerative colitis (UC) are two forms of inflammatory bowel disease (IBD), where the role of gut but not skin dysbiosis is well recognized. Inhibitors of TNF have been successful in IBD treatment, but up to a quarter of ...
www.ncbi.nlm.nih.gov